CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. (Q48795538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Antonio Silvani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Marica Eoli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

A Salmaggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

B Pollo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

C Marras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M R Balestrini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

L Fariselli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

G Broggi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A Boiardi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

287-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-004-7327-y

6 January 2020

exact match

0 references

cites work

Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

1 reference

12 December 2020

Clinical outcome of supratentorial astrocytoma WHO grade II.

1 reference

12 December 2020

CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.

1 reference

12 December 2020

Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt

1 reference

12 December 2020

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

1 reference

12 December 2020

Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients

1 reference

12 December 2020

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

1 reference

12 December 2020

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.

1 reference

12 December 2020

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

1 reference

12 December 2020

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.

1 reference

12 December 2020

Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas.

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

12 December 2020

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

1 reference

12 December 2020

Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas

1 reference

12 December 2020

Supratentorial gliomas: a comparative study by grade and histologic type.

1 reference

12 December 2020

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

1 reference

12 December 2020

Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.

1 reference

12 December 2020

Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?

1 reference

12 December 2020

Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.

1 reference

12 December 2020

Prognostic factors for low-grade gliomas.

1 reference

12 December 2020

Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.

1 reference

12 December 2020

Cellular proliferation in pilocytic and diffuse astrocytomas.

1 reference

12 December 2020

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.

1 reference

12 December 2020

Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas

1 reference

12 December 2020

10.1007/S11060-004-7327-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16132525%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference